Literature DB >> 1322369

Differential morphologic and metabolic alterations in permissive versus nonpermissive murine macrophages infected with Legionella pneumophila.

Y Yamamoto1, T W Klein, K Brown, H Friedman.   

Abstract

Legionella pneumophila infection of macrophages from permissive guinea pigs and from A/J mice compared with infection of cells from nonpermissive BDF1 mice was studied by electron microscopy. The cells from the BDF1 mice were nonpermissive for legionella growth in vitro and showed few if any bacteria in phagosomes by electron microscopic examination. Similar electron micrographic examination of macrophages from A/J mice permissive for legionella growth showed numerous intact intracellular bacteria within 24 to 48 h of culture and the transition of intracellular bacteria from localization in a few large vacuoles early in the course of infection to later localization in areas surrounded and studded by ribosomes. These electron microscopic observations were similar to those seen in the case of guinea pig macrophages infected with legionellae. Biochemical studies of macrophages from permissive versus nonpermissive animals showed little or no differences in respiratory burst and lysosomal enzyme activity for macrophages from all animals tested. However, when zymosan was used as a stimulant, macrophages from the nonpermissive mouse strain produced a larger amount of H2O2 and O2- than did cells from permissive guinea pigs or A/J mice. However, legionella vaccine itself induced no detectable or very little H2O2 and O2- in macrophages tested from any source. These results suggest that permissiveness of A/J mouse macrophages to legionella growth may involve mechanisms similar to those occurring in guinea pig macrophages in terms of morphologic and possibly even biochemical events. The relatively higher production of reactive oxygens by BDF1 mouse macrophages in response to zymosan correlated with nonpermissiveness for legionella growth, although further analysis is necessary to link these observations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322369      PMCID: PMC257306          DOI: 10.1128/iai.60.8.3231-3237.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Susceptibility of Legionella pneumophila to oxygen-dependent microbicidal systems.

Authors:  R M Locksley; R F Jacobs; C B Wilson; W M Weaver; S J Klebanoff
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

3.  Human serum beta-glucuronidase; its measurement and some of its properties.

Authors:  W H Fishman; K Kato; C L Anstiss; S Green
Journal:  Clin Chim Acta       Date:  1967-03       Impact factor: 3.786

4.  Legionella pneumophila growth in macrophages from susceptible mice is genetically controlled.

Authors:  Y Yamamoto; T W Klein; H Friedman
Journal:  Proc Soc Exp Biol Med       Date:  1991-04

Review 5.  Human neutrophil antimicrobial activity.

Authors:  E L Thomas; R I Lehrer; R F Rest
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  Markedly enhanced production of gamma interferon in murine T lymphocytes treated with lentil lectin and the diterpene ester, mezerein.

Authors:  J L Taylor; J J Sedmak; P Jameson; Y G Lin; S E Grossberg
Journal:  J Interferon Res       Date:  1984

7.  Fate of Legionella pneumophila Philadelphia-1 strain in resident, elicited, activated, and immune peritoneal macrophages of guinea pigs.

Authors:  S Yoshida; Y Mizuguchi; Y Nikaido; M Mitsuyama; K Nomoto
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

8.  Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro.

Authors:  H Friedman; R Widen; T Klein; L Searls; K Cabrian
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

9.  Interferon-gamma induced resistance to Legionella pneumophila in susceptible A/J mouse macrophages.

Authors:  T W Klein; Y Yamamoto; H K Brown; H Friedman
Journal:  J Leukoc Biol       Date:  1991-01       Impact factor: 4.962

10.  Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures.

Authors:  Y Yamamoto; T W Klein; C A Newton; R Widen; H Friedman
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

View more
  6 in total

1.  Difference in Legionella pneumophila growth permissiveness between J774.1 murine macrophage-like JA-4 cells and lipopolysaccharide (LPS)-resistant mutant cells, LPS1916, after stimulation with LPS.

Authors:  F Kura; K Suzuki; H Watanabe; Y Akamatsu; F Amano
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

2.  Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III).

Authors:  S J Gebran; Y Yamamoto; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  2-Deoxy-D-glucose inhibits intracellular multiplication and promotes intracellular killing of Legionella pneumophila in A/J mouse macrophages.

Authors:  M Ogawa; S Yoshida; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

4.  Legionella pneumophila replication vacuoles mature into acidic, endocytic organelles.

Authors:  S Sturgill-Koszycki; M S Swanson
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

Review 5.  The many forms of a pleomorphic bacterial pathogen-the developmental network of Legionella pneumophila.

Authors:  Peter Robertson; Hany Abdelhady; Rafael A Garduño
Journal:  Front Microbiol       Date:  2014-12-22       Impact factor: 5.640

6.  Dot/Icm-Dependent Restriction of Legionella pneumophila within Neutrophils.

Authors:  Christopher T D Price; Hannah E Hanford; Aruna Vashishta; Mateja Ozanic; Marina Santic; Silvia Uriarte; Yousef Abu Kwaik
Journal:  mBio       Date:  2021-05-26       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.